VAERS Explorer
Back to explore

Report #2845192

Received Jun 16, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (2)

AgeusiaTaste disorder

Symptom narrative

Loss of taste; This non-serious case was reported by a consumer and described the occurrence of taste loss in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included chronic obstructive pulmonary disease, atrial fibrillation and spinal stenosis. Concomitant products included oxycodone hydrochloride (Oxycodone) and metoprolol succinate (Metoprolol). On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced taste loss (Verbatim: Loss of taste). The outcome of the taste loss was unknown. It was unknown if the reporter considered the taste loss to be related to Shingrix. It was unknown if the company considered the taste loss to be related to Shingrix. Additional Information: GSK receipt date: 07-JUN-2025 Consumer stated that before loss of taste, both salt & sweet were intensified, way too strong for patient and patient would always been an addict of both most through life. Patient had antibiotics.

Current illness

Atrial fibrillation; Chronic obstructive pulmonary disease; Spinal stenosis

Other medications

OXYCODONE; METOPROLOL

Report #2845192 · VAERS Explorer